Missing/wrong data?
Log in to edit
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
scientific article
Author/s
author: James Chih-Hsin Yang, Ann-Lii Cheng, Eunice L Kwak
Work details
Publication date
November 24, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.